Results 21 to 30 of about 117,037 (362)
The Role of Esophageal PH-metri Test on Gastro-Esophageal Reflux Disease Diagnosis [PDF]
, 2008 Gastro-esophageal reflux disease is a pathological condition of esophagus which is caused by gastric content reflux into esophagus. There is an increased prevalence of gastro-esophageal reflux disease.
Abdullah, M. (Murdani) +7 more
core +1 more source
Nonesophageal Eosinophilic Gastrointestinal Disorders: Clinical Care and Future Directions [PDF]
, 2018 Eosinophilic gastrointestinal disorders are a set of conditions with a wide range of clinical manifestations and treatment modalities. The disorders are suspected to result from an abnormal inflammatory response to allergen(s), and individuals may ...
Gupta, Sandeep K., Naramore, Sara
core +1 more source
Dermatology Practical & Conceptual, 2015 Background: Sweet’s syndrome, also referred to as acute febrile neutrophilic dermatosis, can either occur as an idiopathic disorder or associated with another condition, including cancer, or induced by exposure to a drug.
Philip R. Cohen
doaj +1 more source
Use of Proton Pump Inhibitors in Hungary: Mixed-Method Study to Reveal Scale and Characteristics
Frontiers in Pharmacology, 2020 BackgroundDue to their efficacy and tolerability, utilization of proton pump inhibitors (PPI) has significantly increased worldwide. Parallel to the clinical benefits, potential long-term side effects have been observed, which, along with increasing ...
Mária Matuz +7 more
doaj +1 more source
Proton Pump Inhibitors and Clopidogrel [PDF]
Cardiovascular Therapeutics, 2010 Proton pump inhibitors are often prescribed for patients on clopidogrel to prevent gastrointestinal bleeding complications. Recent data suggest higher rates of adverse cardiovascular events in patients on proton pump inhibitors and clopidogrel, in comparison to patients on clopidogrel only.
Ron Waksman, Michael A. Gaglia
openaire +2 more sources
Proton Pump Inhibitors and Gastritis
Journal of Clinical Biochemistry and Nutrition, 2008 Proton pump inhibitors (PPIs) are novel compounds that strongly inhibit the H(+)/K(+)-ATPase in the gastric parietal cells to cause profound suppression of acid secretion. Acid-generating ATPase, also known as vacuolar-type ATPase, is located in the lysozomes of leukocytes and osteoclasts and its activity is also reportedly influenced by treatment with
Toshifumi Hibi +2 more
openaire +4 more sources
Intestinal colonization due to Escherichia coli ST131: Risk factors and prevalence [PDF]
, 2018 Background Escherichia coli sequence type 131 (ST131) is a successful clonal group that has dramatically spread during the last decades and is considered an important driver for the rapid increase of quinolone resistance in E. coli.
A Talaminos +10 more
core +1 more source
Journal of Indian Academy of Oral Medicine and Radiology, 2020 Background: Oral leukoplakia is a white patch or plaque that cannot be characterized clinically or pathologically as any other disease and is not associated with any physical or chemical causative agent except the use of tobacco.
Nivethitha Nagarajan, S Jayachandran
doaj +1 more source
Proton Pump Inhibitor-Related Gastric Mucosal Changes
Gut and Liver, 2021 Proton pump inhibitors (PPIs) are used worldwide to treat of acid-related disorders such as peptic ulcer and gastroesophageal reflux disease and to prevent gastroduodenal injuries due to nonsteroidal anti-inflammatory drugs.
Gwang Ha Kim
doaj +1 more source
Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study [PDF]
, 2014 Objective: To examine the relation between the type of stress ulcer prophylaxis administered and the risk of postoperative pneumonia in patients undergoing coronary artery bypass grafting. Design: Retrospective cohort study.
Bateman, Brian T +9 more
core +1 more source